EMA Authorised: Ixiaro (Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)) — Valneva Austria GmbH

View source ↗

Summary

EMA authorises Ixiaro (Japanese encephalitis vaccine) for immunization against Japanese encephalitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• IXIARO (inactivated Japanese encephalitis vaccine)

Snippet

Status: Authorised. Therapeutic area: Encephalitis, Japanese;Immunization. MAH: Valneva Austria GmbH. Decision date: 19/03/2021